Publications by authors named "Dongjun Lin"

Claim this Profile
C
CRTC2 Promotes AML Progression and Mediates Mitochondrially-Driven Venetoclax Resistance.
Xiaomei Liang, Yilu Zheng, Bangxue Jiang, Yuling Huang, Jing Tang, Dongjun Lin

FASEB J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LSP1 is a prognostic biomarker associated with apoptosis in acute myeloid leukemia.
Chenxing Zhang, Xiaomei Liang, Bangxue Jiang, Yige Hu, Wenhao Zhong, Dongjun Lin

Biomarkers· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of Apoptosis and Activation of Endoplasmic Reticulum Stress by SJ6986 in Diffuse Large B-cell Lymphoma.
Chenxing Zhang, Bangxue Jiang, Xiaomei Liang, Yinting Chen, Zhaozheng Li, Dongjun Lin

Anticancer Agents Med Chem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.
Yiling Ye, Xinyu Liu, Huajuan Dai, Jing Hu, Guopan Yu, Dongjun Lin, Ren Lin

Br J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.
Ke Zhao, Ren Lin, Zhiping Fan, Zhen Li, Xiaoyong Chen, Dongjun Lin

Exp Hematol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-associated subpopulation of B cells: a multicenter prospective study.
Yuanchen Ma, Jieying Chen, Zhiping Fan, Jiahao Shi, Gang Li, Jialing Liu, Dongjun Lin

EBioMedicine· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Nicotinamide mononucleotide promotes osteogenesis and reduces adipogenesis by regulating mesenchymal stromal cells via the SIRT1 pathway in aged bone marrow.
Jie Song, Jing Li, Fangji Yang, Gang Ning, Limin Zhen, Lina Wu, Dongjun Lin

Cell Death Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.
Guopan Yu, Yu Zhang, Sijian Yu, Zhao Yin, Guangyang Weng, Dongjun Lin

Clin Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.
Hui Liu, Hui Xu, Peiru Chi, Zinan Feng, Xiaojun Xu, Ren Lin, Dongjun Lin

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of chain lengths and backbone chirality on the bone-targeting ability of poly(glutamic acid)s.
Jianglong Xia, Wanying Wang, Xiaoxiong Jin, Jing Zhao, Jiaoyu Chen, Dongjun Lin

Biomater Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.
Zhao Yin, Zurong Yao, Dandan Chen, Yu Zhang, Guangyang Weng, Dongjun Lin

J Cancer Res Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study.
Sijian Yu, Yu Zhang, Guopan Yu, Yu Wang, Ruoyang Shao, Dongjun Lin, Ren Lin

J Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic characteristics predict outcomes of acute myeloid leukemia patients with FLT3 mutations receiving venetoclax-based therapy.
Guangyang Weng, Jingya Huang, Na An, Yu Zhang, Guopan Yu, Dongjun Lin

Cancer Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study.
Guangyang Weng, Jingya Huang, Xin He, Tingting Xue, Linlin Yang, Dongjun Lin

Ann Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of iPS cell line (SYSUSHi002-A) from PBMCs of an AML patient with TP53 mutation.
Lihua Yuan, Yaqun Wang, Rongli Xie, Dongjun Lin, Xiaobo Wang

Stem Cell Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle.
Xiaobo Wang, Lihua Yuan, Bo Lu, Dongjun Lin, Xiaojun Xu

Exp Ther Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral delivery of redox-responsive lenalidomide prodrug plus methotrexate for primary central nerve system lymphoma combination therapy.
Hengyu Liu, Tianqi Nie, Xiao Duan, Xinyu Zhang, Yilu Zheng, Haolin Chen, Dongjun Lin

J Control Release· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.
Hua Jin, Yu Zhang, Sijian Yu, Xin Du, Na Xu, Dongjun Lin, Ren Lin

J Hematol Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.
Guangyang Weng, Yu Zhang, Guopan Yu, Tingyue Luo, Sijian Yu, Dongjun Lin

J Intern Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate-risk acute myeloid leukemia in first complete remission undergoing auto-HSCT: An open-label, multicenter, randomized phase 3 trial.
Hui Liu, Fen Huang, Yu Zhang, Meiqing Wu, Na Xu, Dongjun Lin, Ren Lin

Am J Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial.
Haiyan Zhang, Zhiping Fan, Fen Huang, Lijie Han, Yajing Xu, Dongjun Lin, Ren Lin

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a risk model correlated with metabolism based on RNA-binding proteins associated with cell pyroptosis in acute myeloid leukemia.
Ting Bin, Chao Lin, Fang-Jie Liu, Ying Wang, Xiao-Jun Xu, Dong-Jun Lin

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients.
Zhitao Ye, Yishan Li, Xiaobin Tian, Yan Wei, Yanhui Yu, Jianqing Lin, Dongjun Lin

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy.
Wenhao Zhong, Xinyu Zhang, Xiao Duan, Hengyu Liu, Yifen Fang, Dongjun Lin

Acta Biomater· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph- high-risk B-cell acute lymphoblastic leukemia.
Menglin Fan, Yu Wang, Ren Lin, Tong Lin, Fen Huang, Dongjun Lin

Chin Med J (Engl)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis